{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/721-US20210060002A1(Pending) not sealed.pdf"}, "page_content": "[0097] As shown in FIG. 10, berbamine treatment of cells significantly inhibited EV-A71 infection, with ECso being around 17 uM.\n\n[0098] Further, pretreatment of A549 cells with berbamine also abolished lentivirus infection, as shown in FIG. 11.\n\nAntiviral Effect Against JEV in Mice\n\n[0099] Based on the above experimental results, it has been demonstrated that berbamine and its analogues par- ticularly berbamine are potential anti-RNA virus agents.\n\n[0093] The inventors determined the cytotoxicity of ber- bamine in different cell lines including A549 cells, BHK-21 cells, and RD cells. As shown in FIG. 9A and Table 2, it was found that berbamine has lowest cytotoxicity but highest therapeutic index as compared to other alkaloids (Table 3). The inventors therefore assessed the anti-JEV effects of berbamine in a mouse model.\n\n1. A method of preventing or treating a subject suffering from a flavivirus infection by administering an effective amount of berbamine or its analogue to the subject, berbam- has a structure of Formula (I):\n\nthe\n\ning\n\nRD\n\nine\n\nUS 2021/0060002 A1\n\nMar. 4. 2021\n\n12\n\ncontinued\n\nFormula ( I )\n\nFormula ( IV )\n\nOH\n\nN\n\nOH\n\nwherein the flavivirus infection is caused by Japanese\n\nencephalitis virus , Zika virus or Dengue virus .\n\n2. The method of claim 1 , wherein the analogue of\n\n3. The method of claim 2 , wherein the analogue of\n\nberbamine has a structure of Formula ( II ) , ( III ) , or ( IV ) :\n\nberbamine has a structure of Formula ( IIb ) , ( IIIb ) or ( IVb ) :\n\nFormula ( II )\n\nFormula ( IIb )\n\nN\n\n. : 1117\n\nFormula ( III )\n\nFormula ( IIIb )\n\nOH\n\nor\n\nor\n\nN\n\nNO2\n\nUS 2021/0060002 A1\n\nMar. 4, 2021\n\n12\n\n-continued\n\nFormula (1)\n\nwherein the flavivirus infection is caused by Japanese encephalitis virus, Zika virus or Dengue virus.\n\n2. The method of claim 1, wherein the analogue berbamine has a structure of Formula (1D), (III), or (IV):\n\n3. The method of claim 2, wherein the analogue berbamine has a structure of Formula (IIb), (IIIb) or\n\nFormula (IT)", "type": "Document"}}